Morepen Laboratories Limited (NSE:MOREPENLAB)
India · Delayed Price · Currency is INR 49.50
-1.53 (-3.00%)
Jun 19, 2026, 3:30 PM IST
Morepen Laboratories Market Cap
Morepen Laboratories has a market cap or net worth of 27.16 billion as of June 18, 2026. Its market cap has decreased by -23.53% in one year.
Market Cap
27.16B
Enterprise Value
28.33B
Revenue
18.06B
Ranking
n/a
PE Ratio
28.63
Stock Price
49.50
Market Cap Chart
Since October 8, 1999, Morepen Laboratories's market cap has increased from 8.66B to 27.16B, an increase of 213.72%. That is a compound annual growth rate of 4.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 27.16B | 20.70% |
| Dec 31, 2025 | 22.50B | -47.55% |
| Dec 31, 2024 | 42.90B | 72.95% |
| Dec 29, 2023 | 24.81B | 28.39% |
| Dec 30, 2022 | 19.32B | -23.70% |
| Dec 31, 2021 | 25.33B | 83.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Pharmalabs | 58.76B |
| Innova Captab | 53.50B |
| Orchid Pharma | 52.59B |
| RPG Life Sciences | 38.07B |
| Solara Active Pharma Sciences | 28.01B |
| Indoco Remedies | 21.34B |
| Beta Drugs | 18.89B |
| Sakar Healthcare | 17.83B |